European Neuropsychopharmacology
Volume 22, Issue 2 , Pages 81-91, February 2012

Mechanisms of neuropathic pain

Received 8 November 2010; received in revised form 12 April 2011; accepted 14 May 2011. published online 15 June 2011.

Abstract 

Neuropathic pain is a disease of global burden. Its symptoms include spontaneous and stimulus-evoked painful sensations. Several maladaptive mechanisms underlying these symptoms have been elucidated in recent years: peripheral sensitization of nociception, abnormal excitability of afferent neurons, central sensitization comprising pronociceptive facilitation, disinhibition of nociception and central reorganization processes, and sympathetically maintained pain. This review aims to illustrate these pathophysiological principles, focussing on molecular and neurophysiological findings. Finally therapeutic options based on these findings are discussed.

Abbreviations: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazeloproprionic acid, ASIC, acid sensing ion channel, CGRP, calcitonin gene-related peptide, CIP, congenital insensitivity to pain, CRPS, complex regional pain syndrome, DRG, dorsal root ganglion, HPC-nociceptors, nociceptors sensitive to heat, pinch and cold, LPA, lysophosphatidic acid, LTP, long-term potentiation, MAPK, mitogen-activated protein kinase, mGluR, metabotropic G-protein coupled glutamate receptor, NaV, voltage-gated sodium channel, NGF, nerve growth factor, NMDA, N-methyl-D-aspartate, PAG, periaqueductal grey, PEPD, paroxysmal extreme pain disorder, QST, quantitative sensory testing, RVM, rostral ventral medulla, SCS, spinal cord stimulation, SSRI, selective serotonin reuptake inhibitor, TCA, tricyclic antidepressant, TENS, transcutaneous electrical nerve stimulation, TRP, transient receptor potential-channel, TTX, tetrodotoxin

Keywords: Neuropathic pain, Pathophysiology, Sensitization, Reorganization, Sympathetically maintained, Symptoms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(11)00104-0

doi:10.1016/j.euroneuro.2011.05.005

European Neuropsychopharmacology
Volume 22, Issue 2 , Pages 81-91, February 2012